|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
5
|
|
pubmed:dateCreated |
2001-1-4
|
|
pubmed:abstractText |
To establish the therapeutic effect profile of sertraline in major depression. It was hypothesized that the antidepressant effect of sertraline showed three phases: Phase 1 where improvements in anxiety are most pronounced; Phase 2 where the greatest improvements are in depressive symptoms; and Phase 3 where the symptoms of anhedonia show the most improvement. To test this hypothesis, an 8-week, open-label study was conducted.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Oct
|
|
pubmed:issn |
0269-4727
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
25
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
363-71
|
|
pubmed:dateRevised |
2008-5-28
|
|
pubmed:meshHeading |
pubmed-meshheading:11123488-Adolescent,
pubmed-meshheading:11123488-Adult,
pubmed-meshheading:11123488-Aged,
pubmed-meshheading:11123488-Antidepressive Agents,
pubmed-meshheading:11123488-Anxiety,
pubmed-meshheading:11123488-Depression,
pubmed-meshheading:11123488-Female,
pubmed-meshheading:11123488-Humans,
pubmed-meshheading:11123488-Male,
pubmed-meshheading:11123488-Middle Aged,
pubmed-meshheading:11123488-Patient Compliance,
pubmed-meshheading:11123488-Serotonin Uptake Inhibitors,
pubmed-meshheading:11123488-Sertraline
|
|
pubmed:year |
2000
|
|
pubmed:articleTitle |
Sequential improvement of anxiety, depression and anhedonia with sertraline treatment in patients with major depression.
|
|
pubmed:affiliation |
Hôpital de la Salpetrière, Bd de l'hôpital, 75013 Paris, France. paboyer@ext.jussieu.fr
|
|
pubmed:publicationType |
Journal Article
|
